Dechert Advises Alvotech Holdings SA on Its Financing Arrangements in Connection With Its Dual Listing
June 30, 2022
Dechert represented Alvotech Holdings SA, a European integrated specialty biopharmaceutical company focused on the development and manufacturing of high-quality biosimilar medicines, in connection with its negotiations with its first lien private credit investors and equity holders in connection with its first-of-a-kind dual New York and Iceland initial public offering.
The Dechert team advising Alvotech Holdings SA includes Asia finance lead Yang Zhao, partners Daniel Margulies and Giles Belsey and trainee solicitors Siobhan Leung and Christian Jensen.
About Dechert
Dechert is a leading global law firm with 22 offices around the world. The firm advises on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
